72.23 -0.63 (-0.86%)
CELG
| Trade CELG now with |
|
Stock Details
Last Trade:72.23 Change:-0.63 (-0.86%) Prev Close:72.86 Open: 73.15 Days Range:71.92 – 73.19 52 Week Range: 50.11 - 75.11 Volume:3102064 P/E: 25.34EPS:2.85
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 11:26am
Alexion Pharmaceuticals (ALXN) Lower As Biotechs See Pressure
Alexion Pharmaceuticals (ALXN) Lower As Biotechs See Pressure
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) is raising eyebrows today as shares are seeing notable weakness. The stock is down 3.6% mid-day although there is no news to explain the action. ALXN is not the only large biotech seeing weakness,... Read More
Recent Alert on 01/27/12 at 1:49pm
Auriga Reiterates a 'Buy' on Celgene (CELG); Uneventful Q4 Call; Upsides from Multiple Catalysts in 2012
Auriga Reiterates a 'Buy' on Celgene (CELG); Uneventful Q4 Call; Upsides from Multiple Catalysts in 2012
Recent Alert on 01/27/12 at 11:23am
UBS Maintains a 'Buy' on Celgene (CELG); Thoughts on the Stock: 2012 is a Pivotal Year
UBS Maintains a 'Buy' on Celgene (CELG); Thoughts on the Stock: 2012 is a Pivotal Year
Recent Alert on 01/27/12 at 10:03am
Canaccord Genuity Maintains a 'Hold' on Celgene (CELG); Big Revlimid Regulatory Catalyst Ahead
Canaccord Genuity Maintains a 'Hold' on Celgene (CELG); Big Revlimid Regulatory Catalyst Ahead
View AllRecent Press Releases
Press Release on 02/09/12 at 8:01am
Acetylon Announces $15 Million Strategic Equity Investment by Celgene Corporation
Acetylon Announces $15 Million Strategic Equity Investment by Celgene Corporation
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 02/07/12 at 3:18pm
5 Solid Biotechs That Have Delivered Positive Earnings Surprises Recently
5 Solid Biotechs That Have Delivered Positive Earnings Surprises Recently
Blog Posts on 01/30/12 at 9:07am
Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach
Verastem IPO Validates Investor Interest In Cancer Stem Cell Approach